​

Mereo BioPharma Group (MREO) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Mereo BioPharma Group Revenue Highlights

00

Mereo BioPharma Group Revenue by Period

Mereo BioPharma Group Revenue by Year

DateRevenueChange
2024-12-31--100.00%
2023-12-31$10.00M563.57%
2022-12-31$1.51M-95.87%
2021-12-31$36.46M9178.37%
2020-12-31$393.00K-422.13%
2019-12-31$-122.00K100.00%
2018-12-31--100.00%
2017-12-31$-3.29M100.00%
2016-12-31--

Mereo BioPharma Group generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Mereo BioPharma Group Revenue by Quarter

DateRevenueChange
2025-09-30--100.00%
2025-06-30$500.00K100.00%
2025-03-31--100.00%
2024-12-31$1.06M100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$361.10K-32.31%
2023-09-30$533.43K-93.93%
2023-06-30$8.79M146.64%
2023-03-31$3.56M328.36%
2022-12-31$832.01K23.26%
2022-09-30$674.99K100.00%
2022-06-30--100.00%
2022-03-31$462.39K100.00%
2021-12-31--100.00%
2021-09-30$308.58K-99.39%
2021-06-30$50.64M101.49%
2021-03-31$25.13M100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31--

Mereo BioPharma Group generated - in revenue during Q3 2025, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Mereo BioPharma Group Revenue Breakdown

Mereo BioPharma Group Revenue Breakdown by Product

Quarterly Revenue by Product

Product/ServiceJun 25
Operating Segments$500.00K

Mereo BioPharma Group's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Operating Segments (100.00%).

Mereo BioPharma Group Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
SLNSilence Therapeutics$43.26M$224.00K
CAPRCapricor Therapeutics$22.27M-
ACIUAC Immune$14.80M-
PRQRProQR Therapeutics$6.38M$4.48M
IMMPImmutep$3.51M$2.11M
CADLCandel Therapeutics--
ALDXAldeyra Therapeutics--
KYTXKyverna Therapeutics--
CTNMContineum Therapeutics, Inc. Class A--
LXEOLexeo Therapeutics--
MREOMereo BioPharma Group--

MREO Revenue FAQ

What is Mereo BioPharma Group’s yearly revenue?

Mereo BioPharma Group's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $10M, representing an increase of 563.57% compared to 2022. MREO's yearly revenue for 2022 was $1.51M, representing a decrease of -95.87% compared to 2021.

What is Mereo BioPharma Group’s quarterly revenue?

Mereo BioPharma Group's quarterly revenue for Q3 2025 was $0, a -100.00% decrease from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $500K, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). MREO's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Mereo BioPharma Group’s revenue growth rate?

Mereo BioPharma Group's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.